MAPT and Alzheimer disease: The molecular mechanism whereby amyloid and Tau pathologies contribute to AD might depend on the influence of Aβ on kinases such as GSK-3β [47, 48], which might result in the phosphorylation of tau at many sites, including T181 and pT217 [34].